| >> In early 2022 Krajmalnik-Brown and colleagues patented a specific bacterial formulation and spun-off a commercial company called Gut-Brain Axis Therapeutics. I was a little surprised to see this. So the university researchers use time and money from the university to make a discovery, extending on previous published research, and then patent it and start their own for-profit? Excuse my ignorance, but is that how it's done generally? Where's the upside for all those who are potentially affected? It kinda makes sense - Presumably the university is involved somewhere still, and it needs to be commercialised somehow, but.. |
https://skysonginnovations.com/startups/list/
It's interesting they got a lot of funding from over 100 families with autism children:
https://skysonginnovations.com/startups/list/